Pages that link to "Q39418393"

The following pages link to A Formulation Strategy for Gamma Secretase Inhibitor ELND006, a BCS Class II Compound: Development of a Nanosuspension Formulation with Improved Oral Bioavailability and Reduced Food Effects in Dogs (Q39418393):

Displaying 2 items.

• Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds (Q38021953) (← links)
• Recent advancements in mechanical reduction methods: particulate systems (Q38132471) (← links)